Also, back to what EBS said, why are KOLs that have been being paid by Roche and BMS (?) speaking at our symposium about combination drugs targeting the immune system. Would they risk being part of a discussion that is not tied to their sugar daddies?
News 
Market Data 
Discover 
AI
